Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 33.62M INR in the quarter ending June 30, 2026, a decrease of -98.80%. This brings the company's revenue in the last twelve months to 30.53M, down -99.81% year-over-year.

• Revenue (ttm): 30.53M
• Revenue Growth: -99.81%
• P/S Ratio: 66.63
• Revenue / Employee: 17.09K
• Employees: 1,786
• Market Cap: 2.03B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	-	-	-
Mar 31, 2025	16.70B	-142.05M	-0.84%
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error